Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
Titel:
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
Auteur:
Martinello, Marianne Bhagani, Sanjay Shaw, David Orkin, Chloe Cooke, Graham Gane, Edward Iser, David Ustianowski, Andrew Kulasegaram, Ranjababu Stedman, Catherine Tu, Elise Grebely, Jason Dore, Gregory J. Nelson, Mark Matthews, Gail V.